Update on the management of primary immune thrombocytopenia in adults

Catherine Lambert Published in the journal : December 2021 Category : Actualités thérapeutiques

Summary :

In recent years, the management of primary immune thrombocytopenic purpura (ITP) has undergone a profound change, owing to an improved understanding of its pathophysiology, the development of new targeted therapeutic molecules, and the updated guidelines of numerous scientific societies, including the Belgian Hematology Society (BHS). The purpose of this article is to review the diagnostic methods, describe both the modalities and objectives of treatment in 2021, and discuss the new therapeutic options made available to us.

Key Words

ITP, guidelines, therapeutic innovations